Evidence map›Paper›PMID 33481930›Full record

Observational studyPloS one2021

Derivation and validation of a clinical severity score for acutely ill adults with suspected COVID-19: The PRIEST observational cohort study.

Steve Goodacre, Ben Thomas, Laura Sutton, Matthew Burnsall, Ellen Lee, Mike Bradburn, Amanda Loban, Simon Waterhouse, Richard Simmonds, Katie Biggs and 14 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
21.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Usefulness of the CHAMicroorganisms · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 1 country.

Steve GoodacreSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0003-0803-8444
Ben ThomasSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-6659-6930
Laura SuttonSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Matthew BurnsallSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Ellen LeeSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Mike BradburnSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Amanda LobanSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Simon WaterhouseSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Richard SimmondsSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0001-5024-8272
Katie BiggsSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Carl MarincowitzSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Jose SchutterSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Sarah ConnellySchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Elena SheldonSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Jamie HallSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Emma YoungSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0001-9797-0123
Andrew BentleyIntensive Care, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.
Kirsty ChallenEmergency Department, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, United Kingdom.
Chris FitzsimmonsEmergency Department, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.
Tim HarrisEmergency Department, Barts Health NHS Trust, London, United Kingdom.
Fiona LeckySchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0001-6806-0921
Andrew LeeSchool of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom.
Ian MaconochieEmergency Department, Imperial College Healthcare NHS Trust, London, United Kingdom.
Darren WalterEmergency Department, Manchester University NHS Foundation Trust, Wythenshawe Hospital, Manchester, United Kingdom.
University of Sheffield · GBManchester University NHS Foundation Trust · GBBarts Health NHS Trust · GBImperial College Healthcare NHS Trust · GBLancashire Teaching Hospitals NHS Foundation Trust · GBSheffield Children's NHS Foundation Trust · GB

Funding

Department of Health 11/46/07
6 · The paper itself

Abstract

objectivesWe aimed to derive and validate a triage tool, based on clinical assessment alone, for predicting adverse outcome in acutely ill adults with suspected COVID-19 infection.

methodsWe undertook a mixed prospective and retrospective observational cohort study in 70 emergency departments across the United Kingdom (UK). We collected presenting data from 22445 people attending with suspected COVID-19 between 26 March 2020 and 28 May 2020. The primary outcome was death or organ support (respiratory, cardiovascular, or renal) by record review at 30 days. We split the cohort into derivation and validation sets, developed a clinical score based on the coefficients from multivariable analysis using the derivation set, and the estimated discriminant performance using the validation set.

resultsWe analysed 11773 derivation and 9118 validation cases. Multivariable analysis identified that age, sex, respiratory rate, systolic blood pressure, oxygen saturation/inspired oxygen ratio, performance status, consciousness, history of renal impairment, and respiratory distress were retained in analyses restricted to the ten or fewer predictors. We used findings from multivariable analysis and clinical judgement to develop a score based on the NEWS2 score, age, sex, and performance status. This had a c-statistic of 0.80 (95% confidence interval 0.79-0.81) in the validation cohort and predicted adverse outcome with sensitivity 0.98 (0.97-0.98) and specificity 0.34 (0.34-0.35) for scores above four points.

conclusionA clinical score based on NEWS2, age, sex, and performance status predicts adverse outcome with good discrimination in adults with suspected COVID-19 and can be used to support decision-making in emergency care. REGISTRATION: ISRCTN registry, ISRCTN28342533, http://www.isrctn.com/ISRCTN28342533.

Indexed as

AdultAgedAged, 80 and overCOVID-19FemaleHumansMaleMiddle AgedPrognosisProspective StudiesRetrospective StudiesRisk AssessmentSARS-CoV-2Severity of Illness IndexUnited Kingdom

Identifiers

PMID33481930
PMCPMC7822515
OpenAlexW3121562086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.